Ticker Details
INmune Bio Inc. Common stock
IPO Date:	February 4, 2019
Sector:	Healthcare
Industry:	Biotechnology
Market Cap:	$34.83M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.34 | 3.83%
Avg Daily Range (30 D):	$0.05 | 3.38%
Avg Daily Range (90 D):	$0.06 | 3.55%

Institutional Daily Volume
Avg Daily Volume:	.31M
Avg Daily Volume (30 D):	.33M
Avg Daily Volume (90 D):	.37M

Trade Size
Avg Trade Size (Sh.):	134
Avg Trade Size (Sh.) (30 D):	162
Avg Trade Size (Sh.) (90 D):	164

Institutional Trades
Total Institutional Trades:	26
Avg Institutional Trade:	$1.45M
Avg Institutional Trade (30 D):	$2M
Avg Institutional Trade (90 D):	$2M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.74M
Avg Closing Trade (30 D):	$2M
Avg Closing Trade (90 D):	$2M
Avg Closing Volume:	185.19K

News

Dec 5, 2025 @ 12:00 PM Peer Reviewed Study Highlights Therapeutic Potenti... Source: Dr. Nikita M. Patel

Jul 31, 2025 @ 11:00 AM INmune Bio Inc. to Report Second Quarter 2025 Fina... Source: Inmune Bio Inc.

Jun 26, 2025 @ 8:00 PM INmune Bio Inc. to Announce Top Line Results from ... Source: Inmune Bio Inc.

Jul 19, 2024 @ 9:53 PM Inmune Bio re-elects directors, ratifies auditor -... Source: Natashya Angelica

Jul 12, 2024 @ 11:37 AM Zura Bio initiates exchange offer for warrants By ... Source: Ismeta Mujdragic

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-2.12	$-.24	$-1.05
Diluted EPS	$-2.12	$-.24	$-1.05
Revenue	$.05M	$M	$M
Gross Profit
Net Income / Loss	$-49.89M	$-6.47M	$-24.46M
Operating Income / Loss	$-51.38M	$-7.43M	$-24.57M
Cost of Revenue
Net Cash Flow	$6.35M	$-5.64M	$12.42M
PE Ratio